PharmTech Polls Archive - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PharmTech Polls Archive

Pharmaceutical Technology

Welcome to PharmTech Polls! Participate in our current poll and make your opinion count. And don’t forget to check out the poll archive to see past questions and responses.

Click here for the current poll on "biosimilars;

To comment on this or any past poll, email us.

 

Poll Archive

Click here for the results of "PAT advances"

Click here for the results of "regulatory enforcement"

Click here for the results of "industry changes"

Click here for the results of "tablet splitting"

Click here for the results of "trade shows"

Click here for the results of "preventing counterfeiting"

Click here for the results of "patent cliff"

Click here for the results of "FDA confidentiality"

Click here for the results of "European pharmacovigilance activities"

Click here for the results of "generic drug user fees"

Click here for the results of "European legislation"

Click here for the results of "emerging markets"

Click here for the results of "drug settlements"

Click here for the results of "energy efficiency"

Click here for the results of "the Affordable Care Act"

Click here for the results of "drug shortages"

Click here for the results of "transparency"

Click here for the results of "significant changes"

Click here for the results of "quality management"

Click here for the results of "analytical equipment"

Click here for the results of "DTC advertising"

Click here for the results of "biologics manufacturing"

Click here for the results of "powder properties"

Click here for the results of "powder properties"

Click here for the results of "sterile manufacturing"

Click here for the results of "social media"

Click here for the results of "USP monographs"

Click here for the results of "API manufacturing"

Click here for the results of "lyophilisation advances"

Click here for the results of "injection technologies"

Click here for the results of "oral drug delivery"

Click here for the results of "generic drug user fees"

Click here for the results of "solid dosage innovation"

Click here for the results of "small molecule API outsourcing"

Click here for the results of "USP monographs"

Click here for the results of "anticounterfeiting solutions"

Click here for the results of "quality by design and APIs"

Click here for the results of "outsourcing biologics"

Click here for the results of "FDA biosimilars strategy"

Click here for the results of "highly potent APIs"

Click here for the results of "biosimilars"

Click here for the results of "strategies for emerging markets"

Click here for the results of "atypical actives"

Click here for the results of "shared audits"

Click here for the results of "continuous processing"

Click here for the results of "Carbon footprint"

Click here for the results of "Immediate release drug delivery"

Click here for the results of "QbD and CMC"

Click here for the results of "Interphex 2011"

Click here for the results of "FDA transparency"

Click here for the results of "Tableting Equipment"

Click here for the results of "Outsourcing Levels"

Click here for the results of "FDA Recalls"

Click here for the results of "Granulation Techniques"

Click here for the results of "Pharma Forecast for 2011"

Click here for the results of "Needleless Devices"

Click here for the results of "Trade Show Attendance"

Click here for the results of "Regulation of Excipients"

Click here for the results of "Generic-Drug User Fees"

Click here for the results of "Cleanroom Challenges"

Click here for the results of "Small-Molecule Outsourcing"

Click here for the results of "Secondary packaging"

Click here for the results of "Single-use Technologies"

Click here for the results of "Pay-to-Delay"

Click here for the results of "Outsourcing Concerns"

Click here for the results of "Outsourcing"

Click here for the results of "Green Manufacturing Efforts"

Click here for the results of "Biosimilars: Threat or Opportunity?"

Click here for the results of: "Expanding FDA's Power"

Click here for the results of: "Anticounterfeiting Solutions"

Click here for the results of: "Novel Excipients "

Click here for the results of: "Tablet Manufacture"

Click here for the results of: "Equipment Purchasing "

Click here for the results of: "US Healthcare Reform "

Click here for the results of: "Recession"

Click here for the results of: "Ingredient Suppliers "

Click here for the results of:"FDA Spending"

Click here for the results of: "CMO Market "

Click here for the results of: "Lyophilization"

Click here for the results of:" Pharma's Economic Recovery"

Click here for the results of: "M&As in 2010"

Click here for the results off "2010 Innovation"

Click here for the results of: "Oral Drug Delivery"

Click here for the results of:" Drug Delivery Technologies"

Click here for the results of: “The Next Generation of Innovators”

Click here for the results of: “Aseptic Processing”

Click here for the results of: “FDA's 2nd Transparency Meeting”

Click here for the results of: “Small-Molecule Contract Manufacturing”

Click here for the results of: “Packaging Innovation”

Click here for the results of: “Implementing Green Chemistry”

Click here for the results of: “FDA's Enforcement Plan”

Click here for the results of: “Counterfeit Drug Regulation”

Click here for the results of: “Biologics Data Exclusivity”

Click here for the results of: “Stem-Cell Research”

Click here for the results of: “The Influenza Pandemic”

Click here for the results of: “FDA's Transparency Task Force”

Click here for the results of: “The Follow-on Biologics Pathway”

Click here for the results of: “Split FDA?”

Click here for the results of: “QbD for Excipients”

Click here for the results of: “Comparative-Effectiveness Research”

Click here for the results of: “Excipients Issues”

Click here for the results of: “Equipment Reliability”

Click here for the results of: “Outsourcing Decline?”

Click here for the results of: “Daschle Out”

Click here for the results of: “Outsourcing in 2009”

Click here for the results of: “Workforce Reductions”

Click here for the results of: “Daschle for HHS”

Click here for the results of “Pharma Forecast for 2009”

Click here for the results of: “The New FDA Commish”

Click here for the results of: “Harmonization”

Click here for the results of: “Pharma Videos”

Click here for the results of: “Sourcing Ingredients”

Click here for the results of: “The Next President”

Click here for the results of: “Clinical Trial Results”

Click here for the results of: “Off-Label Prescribing”

Click here for the results of: “REACH in the EU”

Click here for the results of: “FDA's Complete Response Letters”

Click here for the results of: “FDA's Black-Box Warnings”

Click here for the results of: “Outsourced or In-House?”

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here